Cite

HARVARD Citation

    Tsagkaris, C. et al. (2022). Polypharmacy and Major Adverse Events in Atrial Fibrillation. Journal of cardiovascular pharmacology. 80 (6), pp. 826-831. [Online]. 
  
Back to record